Table 4.
CVD risk assessment and risk reduction interventions by participants in recent 6 months
| CVD risk assessment in recent 6 months and risk reduction interventions | No | Percentage |
|---|---|---|
| Assessment of CVD risk factors | ||
| Assessed for tobacco use | 61 | 31.8 |
| Assessed for Alcohol use | 36 | 18.8 |
| Assessed for nutrition/dietary intake | 34 | 17.7 |
| Assessed for physical activity | 33 | 17.2 |
| Estimated BMI | 28 | 14.6 |
| Measured Blood pressure | 160 | 83.3 |
| Blood sugar (FBS+PMBS) assessment | 76 | 39.6 |
| Lipid profile | 42 | 21.9 |
| Risk reduction interventions | ||
| Asprin | 19 | 9.9 |
| Statins | 11 | 5.7 |
| Clopidogril | 7 | 3.6 |
| Antihypertensive medications | 142 | 74.0 |
| ACE inhibitor | 64 | 45.1 |
| AT receptor blockage | 49 | 34.5 |
| Calcium channel blocker | 15 | 10.6 |
| Beta-blocker | 14 | 9.9 |
| Advised for low salt diet and blood pressure | 33 | 17.2 |
| Advised for quitting tobacco and cut down alcohol | 45 | 23.4 |
| Advised for physical activity and weight reduction | 56 | 29.2 |
| Counselled for dietary modification and diet plan prepared | 17 | 8.9 |